Multimodal Genomic Predictor of Immunotherapy Success
GEN,
Immune checkpoint inhibitor drugs have added a dimension to physicians’ arsenal in their fight against cancer.
Immune checkpoint inhibitor drugs have added a dimension to physicians’ arsenal in their fight against cancer.
.newsblock { width: 200px; height:200px; float:right; padding-left:15px; padding-right:15px; } Researchers at Johns Hopkins…
Lung cancer. Credit: Jennifer Fairman and Valsamo Anagnostou, Johns Hopkins University Researchers at Johns Hopkins Kimmel…
more news from this sourcecontact patient services Image 1 of 1 Credit: Jennifer Fairman and Valsamo Anagnostou, Johns Hopkins…
Post Views: 1 Researchers at Johns Hopkins Kimmel Cancer Center, the Bloomberg~Kimmel Institute for Cancer Immunotherapy and…
Researchers at Johns Hopkins Kimmel Cancer Center, the Bloomberg~Kimmel Institute for Cancer Immunotherapy and the Johns…
NEW YORK – A team led by researchers at Johns Hopkins University has identified several tumor and immune system features that…